CTRI Number |
CTRI/2016/08/007192 [Registered on: 17/08/2016] Trial Registered Retrospectively |
Last Modified On: |
19/11/2019 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda Diagnostic |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Unhealthy diet as a cause in development of skin disease and its treatment with some Ayurvedic drugs |
Scientific Title of Study
|
Evaluation of Viruddha Ahara in the Pathogenesis of Kustha With Special Reference to VicharchikÄ And its Management In the Purview of, "Viruddha Ashanajan Rogan Pratihanti Virechanam" |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Manisha Talekar |
Designation |
PG Scholar |
Affiliation |
National Institute of Ayurveda jaipur |
Address |
PG Department of Roganidana evam Vikriti Vijnana NIA Jaipur PG Department of Roganidana evam Vikriti Vijnana NIA Jaipur Jaipur RAJASTHAN 302002 India |
Phone |
|
Fax |
|
Email |
dr.mani21jan@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Sisir Kumar mandal |
Designation |
Assistant Professor |
Affiliation |
National Institute of Ayurveda jaipur |
Address |
PG Department of Roganidana evam Vikriti Vijnana NIA Jaipur PG Department of Roganidana evam Vikriti Vijnana NIA Jaipur Jaipur RAJASTHAN 302002 India |
Phone |
|
Fax |
|
Email |
drskmandal2008@rediffmail.com |
|
Details of Contact Person Public Query
|
Name |
Manisha Talekar |
Designation |
PG Scholar |
Affiliation |
National Institute of Ayurveda jaipur |
Address |
PG Department of Roganidana evam Vikriti Vijnana NIA Jaipur PG Department of Roganidana evam Vikriti Vijnana NIA Jaipur
RAJASTHAN 302002 India |
Phone |
|
Fax |
|
Email |
dr.mani21jan@gmail.com |
|
Source of Monetary or Material Support
|
Pharmacy Of Ntional Institute Of Ayurveda Jorawar Singh Gate Amer Road JAIPUR 302002 Rajasthan |
|
Primary Sponsor
|
Name |
National Institute of Ayurveda |
Address |
Jorawar singh Gate, Amer road Jaipur, 302002, Rajasthan |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Manisha Talekar |
National Institute of Ayurveda Jaipur |
PG Department of Roganidana evam Vikriti Vijnana NIA Jaipur Jaipur RAJASTHAN |
8824854303
dr.mani21jan@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Departmental Research Committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
Modification(s)
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: L309||Dermatitis, unspecified, having sign and symptoms of vicharchika kustha, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Aragwadha patra lepa |
Aragwadha patra lepa (leaves of Cassia fistula Linn.) along with Takra for local application in sufficient quantity as per area |
Intervention |
Trivrit Churna with Aragwadha patra lepa |
Trivrit Churna (Operculina turpethum Linn.) 6 gm twice daily with Luke warm water for 1 Month.
Aragwadha patra lepa (leaves of Cassia fistula Linn.) along with Takra for local application in sufficient quantity as per area |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
70.00 Year(s) |
Gender |
Both |
Details |
Patient with the classical sign and symptoms of VicarcikÄ Kuá¹£á¹ha viz Kaṇá¸Å« RujÄ Piá¸ikÄ SrÄva Ruká¹£atÄ ÅšyÄva DÄha RÄjÄ«
Patients above 18 years and below 70 years of age
Patients belonging to either gender |
|
ExclusionCriteria |
Details |
The patient suffering from systemic disorders
The pregnant women and lactating mother
Patient less than 18 years and above 70 yrs of age
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
Method of Concealment
|
An Open list of random numbers |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
Developed Dietetic guidelines for the patients of Kustharoga and ointment formulation for these kind of patient |
follow up at every 15 days total duration 1 month |
|
Secondary Outcome
|
Outcome |
TimePoints |
Devoloped patient awareness about faulty dietary habits |
1 month |
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="60" |
Phase of Trial
|
Phase 3 |
Date of First Enrollment (India)
|
13/01/2013 |
Date of Study Completion (India) |
21/09/2014 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="2" Months="1" Days="10" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
yet to published |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
A randomised clinical trial has been designed to assess the efficacy of Trivá¹›ta CÅ«rṇa with Ä€ragvadha Patra Lepa & Ä€ragvadha Patra Lepa alone in the management of VicarcikÄ (Eczema) 63 patients of VicarcikÄ Kuá¹£á¹ha were selected from O.P.D. of RoganidÄna evam Viká¹›ti VijñÄna department of N.I.A. and randomly taken in 2 groups, out of which 60 patients (30 patients each) were completed the trial treatment. Group A received Trivá¹›ta CÅ«rṇa with Ä€ragvadha Patra Lepa & Group B received Ä€ragvadha Patra Lepa alone for 4 weeks. All calculations were calculated through ‘Graph Pad In stat 3’ software. Nitya Virecana (Regular purgation) by Trivá¹›ta along with Ä€ragvadha Patra Lepa (Group A) proved more effective to control Kaṇá¸Å«, SrÄva, DÄha, Piá¸Ä«kÄ, Vaivarṇya, RujÄ & Åšotha. The synergistic actions of Trivá¹›ta along with Ä€ragvadha Patra Lepa are likely to check the etio-pathogenesis of VicarcikÄ Kuá¹£á¹ha (Eczema) and arrest its progress. |